[Clinical characteristics and risk factors of patients with systemic lupus erythematosus and cancer].
Jinyan Guo, Zhigang Ren, Yi-Yi Xuan, Tianfang Li, Xiaojun Liu, Chengzhi Niu, Jieyao Li, Shengyun Liu
Abstract
<0.001) and cancer risk. Long disease course may be a risk factor for SLE patients to develop cancer, whereas hydroxychloroquine could be a protective factor.
Topics & Concepts
MedicineHydroxychloroquineInternal medicineCancerAzathioprineCyclophosphamideGastroenterologyRisk factorLupus erythematosusDiseaseImmunologyChemotherapyAntibodyInfectious disease (medical specialty)Coronavirus disease 2019 (COVID-19)Systemic Lupus Erythematosus ResearchCytokine Signaling Pathways and Interactions